1. Contribution from the Program in Molecular Biology, The University of Texas at Austin, Austin, Texas 78712, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, 5 Research Parkway, P.O. Box 5100, Wallingford, Connecticut 06492-7660, and Division of Medicinal Chemistry, The University of Texas at Austin, Austin, Texas 78712